Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Adapting an Information Tool for People with Medullary Thyroid Cancer

Interviews explore how to make medullary thyroid cancer information easier to understand.

Plain-language title generated from the registry record
Registry title: Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer

Key facts

Where
Houston, United StatesSee the site

Where in United States

  • MD Anderson Cancer CenterHouston, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
M.D. Anderson Cancer Center
Trial code
NCT07142005
Record updated
25 September 2026
Original description
To find good information about medullary thyroid cancer that is easy to understand and reliable, so researchers aim to design some new educational materials to help.Read full original descriptionShow less

Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer

To find good information about medullary thyroid cancer that is easy to understand and reliable, so researchers aim to design some new educational materials to help.

Inclusion: Provision of signed and dated informed consent form; Males and females; Age: ≥18 years old; Identified ethnicity as "Hispanic" or "Latino/Latina"; Ability to read, write, and speak Spanish; Those who are pregnant are eligible to participate; Have or will face this decision, including: a. Participant/survivor - who has medullary thyroid carcinoma, as determined by a clinician or documented in Multi-Institutional Medullary Thyroid Cancer Collaborative Registry; b. Caregiver/family member - of Participant/survivor who has medullary thyroid carcinoma, as nominated by the Participant/survivor.

Exclusion: Individuals with cognitive or psychological impairment (e.g., depression, anxiety, severe mental illness as documented in the registry; Those < age 18; Ethnic identity as non-Hispanic or non-Latino/a individual.

ClinicalTrials.gov NCT07142005